Secondary Logo

Published Ahead-of-Print - Last Updated: April 08, 2019

The editors of this journal are pleased to offer electronic publication of accepted papers prior to print publication. These papers can be cited using the date of access and the unique DOI number. Any final changes in manuscripts will be made at the time of print publication and will be reflected in the final electronic version of the issue.

Disclaimer: Articles appearing in this Published Ahead-of-Print section have been peer-reviewed and accepted for publication in this journal and posted online before print publication. Articles appearing here may contain statements, opinions, and information that have errors in facts, figures, or interpretation. Accordingly, Lippincott Williams & Wilkins, the editors and authors and their respective employees are not responsible or liable for the use of any such inaccurate or misleading data, opinion or information contained in the articles in this section.

Published Ahead-of-Print Articles are available in PDF format only.


PDF Only



PDF Only


Checkpoint inhibitor treatment induces an increase in HbA1c in nondiabetic patients

Gauci, Marie-Léa; Boudou, Philippe; Squara, Pierre-Alexandre; More

Melanoma Research. ., Post Author Corrections: February 26, 2019

Physiologic colonic fluorine-18-fluorodeoxyglucose uptake may predict response to immunotherapy in patients with metastatic melanoma

Boursi, Ben; Werner, Thomas J.; Gholami, Saeid; More

Melanoma Research. ., Post Author Corrections: December 14, 2018


PDF Only


Chondroitin sulfate proteoglycan 4 enhanced melanoma motility and growth requires a cysteine in the core protein transmembrane domain

Yang, Jianbo; Price, Matthew A.; Wanshura, Leah E.C.; More

Melanoma Research. ., Post Author Corrections: February 01, 2019

Immunotargeted therapy in melanoma: patient, provider preferences, and willingness to pay at an academic cancer center

Stenehjem, David D.; Au, Trang H.; Ngorsuraches, Surachat; More

Melanoma Research. ., Post Author Corrections: January 25, 2019

Time trends and age–period–cohort analysis of cutaneous malignant melanoma incidence rates in the Romagna Region (northern Italy), 1986–2014

Mancini, Silvia; Crocetti, Emanuele; Bucchi, Lauro; More

Melanoma Research. ., Post Author Corrections: January 04, 2019

Prognostic significance of distant metastasis-free interval in patients with relapsed melanoma treated with BRAF with or without MEK inhibitors

Bafaloukos, Dimitrios; Papaxoinis, George; Linardou, Helena; More

Melanoma Research. ., Post Author Corrections: December 28, 2018

Recurrence risk of early-stage melanoma of the external ear: an investigation of surgical approach and sentinel lymph node status

Truong, Amanda; Hyngstrom, John R.; Andtbacka, Robert H.I.; More

Melanoma Research. ., Post Author Corrections: December 20, 2018

Combination of ω-3 fatty acids and cisplatin as a potential alternative strategy for personalized therapy of metastatic melanoma: an in-vitro study

Ottes Vasconcelos, Renata; Serini, Simona; de Souza Votto, Ana Paula; More

Melanoma Research. ., Post Author Corrections: December 13, 2018

The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma

Salmi, Satu; Siiskonen, Hanna; Sironen, Reijo; More

Melanoma Research. ., Post Author Corrections: November 05, 2018

A meta-analysis of melanoma risk in industrial workers

Vujic, Igor; Gandini, Sara; Stanganelli, Ignazio; More

Melanoma Research. ., Post Author Corrections: October 26, 2018

Patterns of treatment and BRAF testing with immune checkpoint inhibitors and targeted therapy in patients with metastatic melanoma presumed to be BRAF positive

Ghate, Sameer; Ionescu-Ittu, Raluca; Burne, Rebecca; More

Melanoma Research. ., Post Author Corrections: October 09, 2018

Long-term relative survival from melanoma in Germany 1997–2013

Brunssen, Alicia; Jansen, Lina; Eisemann, Nora; More

Melanoma Research. ., Post Author Corrections: July 17, 2018

Show: